Induced Pluripotent Stem Cell Derived Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
| Taxonomy | ID | Name / Label |
|---|---|---|
| Cell Ontology (CL) | CL:0000034 | stem cell |
| Database | ID | Name | Confidence | [1]
|----------|----|------|------------| [2]
| Cell Ontology | CL:0000034 | stem cell | Medium |
| Cell Ontology | CL:0000049 | common myeloid progenitor | Medium |
Induced pluripotent stem cell (iPSC)-derived neurons are patient-specific neural cells generated by reprogramming adult somatic cells (typically fibroblasts or blood cells) back to a pluripotent state, then directing their differentiation into specific neuronal subtypes. This technology has revolutionized neurodegenerative disease research by providing human disease-relevant cellular models that capture patient-specific genetic backgrounds.
Adult somatic cells are reprogrammed using the Yamanaka factors:
Methods include integration-free episomal vectors, mRNA transfection, or small molecule approaches to avoid genomic disruption.
iPSCs are guided toward neural lineage through:
Directed differentiation protocols yield specific neuron types:
Young neurons require extended culture (months) to achieve:
iPSC technology has enabled:
Living models of human neurodegenerative diseases
Understanding of disease mechanisms inaccessible previously
Discovery of novel therapeutic targets
Patient stratification for clinical trials
Cell-based brain delivery
Stem cell therapy
Alzheimer's disease models
Parkinson's disease models
Gene therapy
Induced Pluripotent Stem Cell Derived Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Induced Pluripotent Stem Cell Derived Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Chatterjee P, et al. (2018). Enhanced synaptic protein and vesicle marker synaptophysin levels in glutamatergic neurons in Parkinson's disease iPSC-derived neurons. Molecular Brain, 11(1): 30. 2018. ↩︎
Sareen D, et al. (2013). Targeting RNA foci in iPSC-derived motor neurons from C9orf72 ALS patients. Acta Neuropathologica Communications, 1(1): 46. 2013. ↩︎